US2011142960A1PendingUtilityA1
Nutritional supplement for osteoarthritis
Assignee: SIERRA MOUNTAIN MINERALS INCPriority: Jul 26, 2004Filed: Feb 15, 2011Published: Jun 16, 2011
Est. expiryJul 26, 2024(expired)· nominal 20-yr term from priority
Inventors:Michael Bentley
A61P 19/02A61K 35/02A61K 36/00A61K 33/12A61K 45/06A61K 33/06
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a method of treating osteoarthritis by administering a mineral composition in the form of a nutritional supplement, where the mineral composition may contain Smectite, Gypsum, Quartz, Feldspar, Jarosite, Kaolinite and/or Zeolite.
Claims
exact text as granted — not AI-modified1 . A dosage form for the treatment of osteoarthritis, consisting essentially of a purified mineral composition and optional excipients, said purified mineral composition consisting essentially of:
a. 25-75% Smectite; b. Gypsum; c. Quartz; d. Feldspar; e. Jarosite; f. Kaolinite; and g. Zeolite; and h. an optional anti-inflammatory; wherein said dosage form is a tablet, capsule, or pill.
2 . The composition of claim 1 , wherein the composition comprises purified silt from a river source.
3 . The composition of claim 1 , wherein said purified mineral composition consists essentially of based on the total amount of components (a) through (g):
a. 50% Smectite; b. 10% Gypsum; c. 10% Quartz; d. 10% Feldspar; e. 10% Jarosite; f. 5% Kaolinite; and g. 5% Zeolite.
4 . The dosage form of claim 1 , wherein the dosage form is in the form of a tablet.
5 . The dosage form of claim 1 , wherein the dosage form is in the form of a capsule.
6 . The dosage form of claim 1 , wherein the dosage form comprises about 2.0 grams of said purified mineral composition.
7 . The dosage form of claim 1 , wherein the optional anti-inflammatory is selected from the group consisting of aspirin, ibuprofen, acetaminophen, naproxen and mixtures thereof.
8 . The dosage form of claim 1 , wherein said purified mineral composition consists essentially of 25-75% Smectite; Gypsum; Quartz; Feldspar; Jarosite; Kaolinite; and Zeolite, in the absence of an anti-inflammatory.Join the waitlist — get patent alerts
Track US2011142960A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.